{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:30:31Z","timestamp":1794684631098,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brazilian Ministry of Health - PROADI program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      To evaluate the prognostic value of peak serum lactate and lactate clearance at several time points in cardiogenic shock treated with temporary mechanical circulatory support (MCS) using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or Impella CP\n                      <jats:sup>\u00ae<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum lactate and clearance were measured before MCS and at 1\u00a0h, 6\u00a0h, 12\u00a0h, and 24\u00a0h post-MCS in 43 patients at four tertiary-care centers in Southern Brazil. Prognostic value was assessed by univariable and multivariable analysis and receiver operating characteristic (ROC) curves for 30-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>VA-ECMO was the most common MCS modality (58%). Serum lactate levels at all time points and lactate clearance after 6\u00a0h were associated with mortality on unadjusted and adjusted analyses. Lactate levels were higher in non-survivors at 6\u00a0h, 12\u00a0h, and 24\u00a0h after MCS. Serum lactate &gt;\u20091.55\u00a0mmol\/L at 24\u00a0h was the best single prognostic marker of 30-day mortality [area under the ROC curve\u2009=\u20090.81 (0.67\u20130.94); positive predictive value\u2009=\u200986%). Failure to improve serum lactate after 24\u00a0h was associated with 100% mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum lactate was an important prognostic biomarker in cardiogenic shock treated with temporary MCS. Serum lactate and lactate clearance at 24\u00a0h were the strongest independent predictors of short-term survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01785-7","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T14:04:39Z","timestamp":1606226679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2150-6337","authenticated-orcid":false,"given":"Fernando Lu\u00eds","family":"Scolari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Vacaro","family":"Fogazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marciane Maria","family":"Rover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcely Gimenes","family":"Bonatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Neves","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Zimerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sganzerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Adams","family":"Goldraich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassiano","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carisi Anne","family":"Polanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis Goulart","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Vugman","family":"Wainstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"1785_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28329","author":"DA Baran","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv. 2019. https:\/\/doi.org\/10.1002\/ccd.28329.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1785_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/17482941.2010.523705","volume":"12","author":"A Shpektor","year":"2010","unstructured":"Shpektor A. Cardiogenic shock: the role of inflammation. Acute Card Care. 2010;12:115\u20138. https:\/\/doi.org\/10.3109\/17482941.2010.523705.","journal-title":"Acute Card Care"},{"key":"1785_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2081-2","volume":"22","author":"YC Yeh","year":"2018","unstructured":"Yeh YC, Lee CT, Wang CH, Tu YK, Lai CH, Wang YC, et al. Investigation of microcirculation in patients with venoarterial extracorporeal membrane oxygenation life support. Crit Care. 2018;22:1\u20139. https:\/\/doi.org\/10.1186\/s13054-018-2081-2.","journal-title":"Crit Care"},{"key":"1785_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Ospina-Tasc\u00f3n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA - J Am Med Assoc. 2019;321:654\u201364. https:\/\/doi.org\/10.1001\/jama.2019.0071.","journal-title":"JAMA - J Am Med Assoc"},{"key":"1785_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ijcard.2016.07.065","volume":"221","author":"F Rigamonti","year":"2016","unstructured":"Rigamonti F, Montecucco F, Boroli F, Rey F, Gencer B, Cikirikcioglu M, et al. The peak of blood lactate during the first 24 h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation. Int J Cardiol. 2016;221:741\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.065.","journal-title":"Int J Cardiol"},{"key":"1785_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","volume":"396","author":"A Combes","year":"2020","unstructured":"Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020;396:199\u2013212. https:\/\/doi.org\/10.1016\/S0140-6736(20)31047-3.","journal-title":"Lancet"},{"key":"1785_CR7","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMra1208943","volume":"369","author":"J-L Vincent","year":"2013","unstructured":"Vincent J-L, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726\u201334. https:\/\/doi.org\/10.1056\/NEJMra1208943.","journal-title":"N Engl J Med"},{"key":"1785_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jcrc.2017.06.022","volume":"42","author":"I Slottosch","year":"2017","unstructured":"Slottosch I, Liakopoulos O, Kuhn E, Scherner M, Deppe AC, Sabashnikov A, et al. Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock. J Crit Care. 2017;42:35\u201341. https:\/\/doi.org\/10.1016\/j.jcrc.2017.06.022.","journal-title":"J Crit Care"},{"key":"1785_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13054-015-1073-8","volume":"19","author":"P Gaudard","year":"2015","unstructured":"Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouvi\u00e8re P, et al. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care. 2015;19:363. https:\/\/doi.org\/10.1186\/s13054-015-1073-8.","journal-title":"Crit Care"},{"key":"1785_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtcvs.2009.04.022","volume":"139","author":"J Song","year":"2000","unstructured":"Song J, Kim M, Yun S, Choo J, Song J, Song H, et al. Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery. J Thorac Cardiovasc Surg. 2000;139:103\u201310. https:\/\/doi.org\/10.1016\/j.jtcvs.2009.04.022.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1785_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehz500","volume":"2019","author":"H Thiele","year":"2019","unstructured":"Thiele H, Ohman EM, De W-T, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update. Eur Heart J. 2019;2019:1\u201315. https:\/\/doi.org\/10.1093\/eurheartj\/ehz500.","journal-title":"Eur Heart J"},{"key":"1785_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1051\/ject\/201951133","volume":"51","author":"B Worku","year":"2019","unstructured":"Worku B, Khin S, Gaudino M, Avgerinos D, Gambardella I, D\u2019Ayala M, et al. A simple scoring system to predict survival after venoarterial extracorporeal membrane oxygenation. J Extra Corpor Technol. 2019;51:133\u20139.","journal-title":"J Extra Corpor Technol"},{"key":"1785_CR13","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jcin.2020.06.037","volume":"13","author":"G Fuernau","year":"2020","unstructured":"Fuernau G, Desch S, de Waha-Thiele S, Eitel I, Neumann FJ, Hennersdorf M, et al. Arterial lactate in cardiogenic shock: prognostic value of clearance versus single values. JACC Cardiovasc Interv. 2020;13:2208\u201316. https:\/\/doi.org\/10.1016\/j.jcin.2020.06.037.","journal-title":"JACC Cardiovasc Interv"},{"key":"1785_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12871-018-0618-1","volume":"18","author":"I Mungan","year":"2018","unstructured":"Mungan I, Kazancl D, Bekta\u015f \u015e, Ademoglu D, Turan S. Does lactate clearance prognosticates outcomes in ECMO therapy: a retrospective observational study. BMC Anesthesiol. 2018;18:1\u20138. https:\/\/doi.org\/10.1186\/s12871-018-0618-1.","journal-title":"BMC Anesthesiol"},{"key":"1785_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/2048872617743194","volume":"7","author":"PB Jensen","year":"2018","unstructured":"Jensen PB, Kann SH, Veien KT, M\u00f8ller-Helgestad OK, Dahl JS, Rud CS, et al. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock. Eur Hear J Acute Cardiovasc Care. 2018;7:53\u201361. https:\/\/doi.org\/10.1177\/2048872617743194.","journal-title":"Eur Hear J Acute Cardiovasc Care"},{"key":"1785_CR16","unstructured":"ELSO. General Guidelines for all ECLS Cases. Extracorpor Life Support Organ 2017:1\u201326."},{"key":"1785_CR17","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1093\/eurheartj\/ehv194","volume":"36","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36:2246\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehv194.","journal-title":"Eur Heart J"},{"key":"1785_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00134-016-4223-9","volume":"42","author":"G Muller","year":"2016","unstructured":"Muller G, Flecher E, Lebreton G, Luyt C-E, Trouillet J-L, Br\u00e9chot N, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016;42:370\u20138. https:\/\/doi.org\/10.1007\/s00134-016-4223-9.","journal-title":"Intensive Care Med"},{"key":"1785_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","volume":"31","author":"RP Moreno","year":"2005","unstructured":"Moreno RP, Metnitz PGH, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3\u2014from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31:1345\u201355. https:\/\/doi.org\/10.1007\/s00134-005-2763-5.","journal-title":"Intensive Care Med"},{"key":"1785_CR20","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira FL, Bota DP, Bross A, M\u00e9lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754. https:\/\/doi.org\/10.1001\/jama.286.14.1754.","journal-title":"JAMA"},{"key":"1785_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/SHK.0000000000001191","volume":"51","author":"M Frydland","year":"2019","unstructured":"Frydland M, M\u00f8ller JE, Wiberg S, Lindholm MG, Hansen R, Henriques JPS, et al. Lactate is a prognostic factor in patients admitted with suspected ST-elevation myocardial infarction. Shock. 2019;51:321\u20137. https:\/\/doi.org\/10.1097\/SHK.0000000000001191.","journal-title":"Shock"},{"key":"1785_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jtcvs.2014.11.052","volume":"149","author":"C-L Li","year":"2015","unstructured":"Li C-L, Wang H, Jia M, Ma N, Meng X, Hou X-T. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: a retrospective observational study. J Thorac Cardiovasc Surg. 2015;149:1445\u201350. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.11.052.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1785_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01482-2","author":"M Masyuk","year":"2019","unstructured":"Masyuk M, Abel P, Hug M, Wernly B, Haneya A, Sack S, et al. Real-world clinical experience with the percutaneous extracorporeal life support system: results from the German Lifebridge \u00ae Registry. Clin Res Cardiol. 2019. https:\/\/doi.org\/10.1007\/s00392-019-01482-2.","journal-title":"Clin Res Cardiol"},{"key":"1785_CR24","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00246-018-2033-2","volume":"40","author":"L Yang","year":"2019","unstructured":"Yang L, Fan Y, Lin R, He W. Blood lactate as a reliable marker for mortality of pediatric refractory cardiogenic shock requiring extracorporeal membrane oxygenation. Pediatr Cardiol. 2019;40:602\u20139. https:\/\/doi.org\/10.1007\/s00246-018-2033-2.","journal-title":"Pediatr Cardiol"},{"key":"1785_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MCC.0000000000000628","volume":"25","author":"G Fuernau","year":"2019","unstructured":"Fuernau G. Lactate and other biomarkers as treatment target in cardiogenic shock. Curr Opin Crit Care. 2019;25:403\u20139. https:\/\/doi.org\/10.1097\/MCC.0000000000000628.","journal-title":"Curr Opin Crit Care"},{"key":"1785_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00024382-200116001-00007","volume":"16","author":"F Harig","year":"2001","unstructured":"Harig F, Hohenstein B, Von Der Emde J, Weyand M. Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. Shock. 2001;16:33\u20138. https:\/\/doi.org\/10.1097\/00024382-200116001-00007.","journal-title":"Shock"},{"key":"1785_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","author":"Y Tang","year":"2020","unstructured":"Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01708.","journal-title":"Front Immunol"},{"key":"1785_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224","volume":"6","author":"A Lauten","year":"2013","unstructured":"Lauten A, Engstr\u00f6m AE, Jung C, Empen K, Erne P, Cook S, et al. Percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock results of the impella-EUROSHOCK-Registry. Circ Hear Fail. 2013;6:23\u201330. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.967224.","journal-title":"Circ Hear Fail"},{"key":"1785_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/openhrt-2018-000987","volume":"6","author":"B Alushi","year":"2019","unstructured":"Alushi B, Douedari A, Froehlig G, Knie W, Wurster TH, Leistner DM, et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart. 2019;6:1\u20139. https:\/\/doi.org\/10.1136\/openhrt-2018-000987.","journal-title":"Open Heart"},{"key":"1785_CR30","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.115.019143","volume":"133","author":"C-H Chang","year":"2016","unstructured":"Chang C-H, Chen H-C, Caffrey JL, Hsu J, Lin J-W, Lai M-S, et al. Survival analysis after extracorporeal membrane oxygenation in critically ill adults. Circulation. 2016;133:2423\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019143.","journal-title":"Circulation"},{"key":"1785_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28307","author":"MB Basir","year":"2019","unstructured":"Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, et al. Improved outcomes associated with the use of shock protocols: updates from the national cardiogenic shock initiative. Catheter Cardiovasc Interv. 2019. https:\/\/doi.org\/10.1002\/ccd.28307.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1894","key":"1785_CR32","doi-asserted-by":"publisher","first-page":"1902.e3","DOI":"10.1016\/j.jtcvs.2018.05.061","volume":"156","author":"T Fux","year":"2018","unstructured":"Fux T, Holm M, Corbascio M, Lund LH, van der Linden J. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: risk factors for mortality. J Thorac Cardiovasc Surg. 2018;156(1894):1902.e3. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.05.061.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1785_CR33","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.1002\/ccd.25247","volume":"83","author":"B Maini","year":"2014","unstructured":"Maini B, Gregory D, Scotti DJ, Buyantseva L. Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives. Catheter Cardiovasc Interv. 2014;83:E183\u201392. https:\/\/doi.org\/10.1002\/ccd.25247.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01785-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:13:46Z","timestamp":1697199226000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01785-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1785"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01785-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-60128\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-60128\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was approved by the ethics committee of Hospital de Cl\u00ednicas de Porto Alegre (N\u00ba2017-0495) and complied with the principles of the Helsinki Declaration (2008 revision). Written informed consent was obtained from all patients or, if the patient was in no clinical condition to provide consent, from a legal guardian or next of kin.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}